1,544 results on '"Buckle, P."'
Search Results
2. Delphi consensus project on prostate-specific membrane antigen (PSMA)–targeted surgery—outcomes from an international multidisciplinary panel
- Author
-
Berrens, Anne-Claire, Scheltema, Matthijs, Maurer, Tobias, Hermann, Ken, Hamdy, Freddie C., Knipper, Sophie, Dell’Oglio, Paolo, Mazzone, Elio, de Barros, Hilda A., Sorger, Jonathan M., van Oosterom, Matthias N., Stricker, Philip D., van Leeuwen, Pim J., Rietbergen, Daphne D. D., Valdes Olmos, Renato A., Vidal-Sicart, Sergi, Carroll, Peter R., Buckle, Tessa, van der Poel, Henk G., and van Leeuwen, Fijs W. B.
- Published
- 2024
- Full Text
- View/download PDF
3. High rates of International Code violations: a cross-sectional study in a region of Canada with low breastfeeding rates
- Author
-
Barry, Susan, Buckle, Hannah, Newhook, Leigh Anne Allwood, Roebothan, Barbara, Howell, Brittany, Gates, Heather, and Twells, Laurie K.
- Published
- 2024
- Full Text
- View/download PDF
4. A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial
- Author
-
Bhaskaran, Divyalakshmi, Savage, Joshua, Patel, Amit, Collinson, Fiona, Mant, Rhys, Boele, Florien, Brazil, Lucy, Meade, Sara, Buckle, Peter, Lax, Siân, Billingham, Lucinda, and Short, Susan C.
- Published
- 2024
- Full Text
- View/download PDF
5. Clinical Trials in Gastroesophageal Cancers: An Analysis of the Global Landscape of Interventional Trials From ClinicalTrials.gov
- Author
-
Ayo S. Falade, Oluwatayo Adeoye, Katherine Van Loon, and Geoffrey C. Buckle
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
PURPOSETo describe the global landscape of clinical research into interventions for gastroesophageal cancers (GECs), with examination of trial characteristics, geographic distribution of trial sites, and factors associated with trial termination.METHODSWe queried ClinicalTrials.gov to identify all completed or terminated phase III interventional studies investigating GECs (esophageal squamous cell carcinoma [ESCC], esophageal adenocarcinoma [EAC], gastroesophageal junctional [GEJ], and gastric adenocarcinoma). Data on all reported trial characteristics were extracted. Pearson's chi-square and Fisher's exact tests were used to compare differences in completed and terminated trials. Multivariate logistic regression evaluated predictors of termination.RESULTSA total of 179 trials were identified; of these, 90% were therapeutic. Most included sites in Asia (61%) and Europe (32%); few included sites in Africa (4%). Thirty percent included sites in low- and middle-income countries (LMICs). Most (70%) focused on gastric or GEJ adenocarcinoma, 13% on EAC and ESCC, and 9% on ESCC alone. Sixteen percent (n = 29) of trials terminated prematurely. In multivariate analysis, study site number, location of recruitment sites, and patient population emerged as predictors of termination. Trials recruiting from US-based sites were more likely to terminate (odds ratio [OR], 7.22 [95% CI, 1.59 to 32.69]). Trials conducted exclusively in LMICs were less likely to terminate (OR, 0.04 [95% CI, 0.01 to 0.59] v conducted in high-income countries [HICs] alone). Studies on ESCC were more likely to terminate (OR, 17.74 [95% CI, 1.49 to 210.69]).CONCLUSIONAlthough 80% of GECs occur in LMICs, trial activity disproportionately occurs in HICs. Few trials focus on EAC/ESCC despite being highly fatal, highlighting an unmet need. Overall, this study highlights (1) a missed opportunity to recruit patients from high-incidence regions globally; and (2) a pressing need for increasing funding, infrastructure, and support for GEC trials in LMICs.
- Published
- 2024
- Full Text
- View/download PDF
6. Human Papillomavirus–Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review
- Author
-
Okerosi, Samuel, Mokoh, Lillian Wairimu, Rubagumya, Fidel, Niyibizi, Brandon Asuman, Nkya, Aslam, Van Loon, Katherine, Buckle, Geoffrey, Bent, Stephen, Ha, Patrick, Fagan, Johannes J, Ng, Dianna, Aswani, Joyce, and Xu, Mary Jue
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Prevention ,Clinical Research ,Cancer ,Sexually Transmitted Infections ,Cervical Cancer ,Dental/Oral and Craniofacial Disease ,Infectious Diseases ,Good Health and Well Being ,United States ,Humans ,Human Papillomavirus Viruses ,Papillomavirus Infections ,Head and Neck Neoplasms ,Papillomaviridae ,Risk Factors ,Oncology and carcinogenesis ,Public health - Abstract
PurposeThe proportion of head and neck cancers (HNCs) with human papillomavirus (HPV) positivity in sub-Saharan Africa (SSA) is poorly characterized. Characterizing this has implications in staging, prognosis, resource allocation, and vaccination policies. This study aims to determine the proportion of HPV-associated HNC in SSA.Materials and methodsThis systematic review included searches from PubMed, EMBASE, Web of Science, African Index Medicus, Google Scholar, and African Journals Online. All English publications reporting the proportion of HNC specimens from SSA patients who tested positive for HPV and/or p16 were included. Study quality was assessed using the National Institutes of Health Quality Assessment Tool for Case Series Studies.ResultsIn this systematic review of 31 studies and 3,850 patients, the overall p16 positivity was 13.6% (41 of 1,037 patients tested) with the highest proportion among oropharyngeal cancers (20.3%, 78 of 384 patients) and the overall HPV polymerase chain reaction positivity was 15.3% (542 of 3,548 samples tested) with the highest proportion among nasopharyngeal cancers (16.5%, 23 of 139 patients). Among the 369 HPV strains detected, the most common genotypes were HPV 16 (226 patients, 59.2%) and HPV 18 (78, 20.4%).ConclusionHPV was found to be associated with a significant proportion of HNC in SSA. The genotypes reported suggest that the nine-valent vaccine and gender-neutral vaccination policies should be considered. Given that these studies may not accurately capture prevalence nor causation of HPV in HNC subsites, additional research is needed to provide a more thorough epidemiologic understanding of HPV-associated HNC in SSA, including risk factors and clinical outcomes.
- Published
- 2023
7. The futility of measuring relative performance of ESG portfolios if ESG investing improves the market performance
- Author
-
Buckle, David
- Published
- 2023
- Full Text
- View/download PDF
8. High rates of International Code violations: a cross-sectional study in a region of Canada with low breastfeeding rates
- Author
-
Susan Barry, Hannah Buckle, Leigh Anne Allwood Newhook, Barbara Roebothan, Brittany Howell, Heather Gates, and Laurie K. Twells
- Subjects
International Code of Marketing of Breast-Milk Substitutes ,Violations ,Breastfeeding ,Canada ,Medicine ,Biology (General) ,QH301-705.5 ,Science (General) ,Q1-390 - Abstract
Abstract Background Exposure to marketing and promotion of commercial milk formula is associated with an increased likelihood of formula-feeding. In 1981, the International Code (IC) of Marketing of Breastmilk Substitutes was adopted by the 34th World Health Assembly to restrict the promotion, marketing and advertising of commercial milk formula and protect breastfeeding. Research Aim The current study examines mothers’ exposure to violations of the IC in Newfoundland and Labrador, a province of Canada with low breastfeeding rates. Methods A cross-sectional online survey measured exposure to IC violations (e.g., marketing, advertising and promotion of commercial milk formula) by mothers of infants less than two years old (n = 119). Data were collected on type, frequency, and location of violation. Results Most participants (87%, n = 104/119) reported exposure to at least one IC violation. Of this group (n = 104): 94% received coupons or discount codes for the purchase of commercial milk formula; 88% received free samples of commercial milk formula from manufacturers, and 79% were contacted directly by commercial milk formula companies via email, text message, mail or phone for advertising purposes. One-third (n = 28/104, 27%) observed commercial milk formula promotional materials in health care facilities. The most frequent locations were violations occurred were doctors’ offices (79%), supermarkets(75%), and pharmacies (71%). Conclusion The majority of mothers of young infants were exposed to violations of the IC involving the marketing, advertising and promotion of commercial milk formula. Companies producing commercial milk formula reached out directly to new mothers to offer unsolicited promotions and free samples of commercial milk formula.
- Published
- 2024
- Full Text
- View/download PDF
9. A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial
- Author
-
Divyalakshmi Bhaskaran, Joshua Savage, Amit Patel, Fiona Collinson, Rhys Mant, Florien Boele, Lucy Brazil, Sara Meade, Peter Buckle, Siân Lax, Lucinda Billingham, and Susan C. Short
- Subjects
Randomised phase II trial ,Glioblastoma ,Cannabinoids ,Sativex ,Nabiximols ,Brain cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Glioblastoma (GBM) is the most common adult malignant brain tumour, with an incidence of 5 per 100,000 per year in England. Patients with tumours showing O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation represent around 40% of newly diagnosed GBM. Relapse/tumour recurrence is inevitable. There is no agreed standard treatment for patients with GBM, therefore, it is aimed at delaying further tumour progression and maintaining health-related quality of life (HRQoL). Limited clinical trial data exist using cannabinoids in combination with temozolomide (TMZ) in this setting, but early phase data demonstrate prolonged overall survival compared to TMZ alone, with few additional side effects. Jazz Pharmaceuticals (previously GW Pharma Ltd.) have developed nabiximols (trade name Sativex®), an oromucosal spray containing a blend of cannabis plant extracts, that we aim to assess for preliminary efficacy in patients with recurrent GBM. Methods ARISTOCRAT is a phase II, multi-centre, double-blind, placebo-controlled, randomised trial to assess cannabinoids in patients with recurrent MGMT methylated GBM who are suitable for treatment with TMZ. Patients who have relapsed ≥ 3 months after completion of initial first-line treatment will be randomised 2:1 to receive either nabiximols or placebo in combination with TMZ. The primary outcome is overall survival time defined as the time in whole days from the date of randomisation to the date of death from any cause. Secondary outcomes include overall survival at 12 months, progression-free survival time, HRQoL (using patient reported outcomes from QLQ-C30, QLQ-BN20 and EQ-5D-5L questionnaires), and adverse events. Discussion Patients with recurrent MGMT promoter methylated GBM represent a relatively good prognosis sub-group of patients with GBM. However, their median survival remains poor and, therefore, more effective treatments are needed. The phase II design of this trial was chosen, rather than phase III, due to the lack of data currently available on cannabinoid efficacy in this setting. A randomised, double-blind, placebo-controlled trial will ensure an unbiased robust evaluation of the treatment and will allow potential expansion of recruitment into a phase III trial should the emerging phase II results warrant this development. Trial registration ISRCTN: 11460478. ClinicalTrials.Gov: NCT05629702.
- Published
- 2024
- Full Text
- View/download PDF
10. An international report on bacterial communities in esophageal squamous cell carcinoma
- Author
-
Nomburg, Jason, Bullman, Susan, Nasrollahzadeh, Dariush, Collisson, Eric A, Abedi‐Ardekani, Behnoush, Akoko, Larry O, Atkins, Joshua R, Buckle, Geoffrey C, Gopal, Satish, Hu, Nan, Kaimila, Bongani, Khoshnia, Masoud, Malekzadeh, Reza, Menya, Diana, Mmbaga, Blandina T, Moody, Sarah, Mulima, Gift, Mushi, Beatrice P, Mwaiselage, Julius, Mwanga, Ally, Newton, Yulia, Ng, Dianna L, Radenbaugh, Amie, Rwakatema, Deogratias S, Selekwa, Msiba, Schüz, Joachim, Taylor, Philip R, Vaske, Charles, Goldstein, Alisa, Stratton, Michael R, McCormack, Valerie, Brennan, Paul, DeCaprio, James A, Meyerson, Matthew, Mmbaga, Elia J, and Van Loon, Katherine
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Human Genome ,Esophageal Cancer ,Microbiome ,Rare Diseases ,Cancer Genomics ,Clinical Research ,Dental/Oral and Craniofacial Disease ,Genetics ,Prevention ,Digestive Diseases ,Infectious Diseases ,Cancer ,Infection ,Bacteria ,Esophageal Neoplasms ,Esophageal Squamous Cell Carcinoma ,Humans ,Kenya ,Microbiota ,Africa ,esophageal cancer ,esophageal squamous cell carcinoma ,Fusobacterium ,microbiome ,Oncology & Carcinogenesis ,Oncology and carcinogenesis - Abstract
The incidence of esophageal squamous cell carcinoma (ESCC) is disproportionately high in the eastern corridor of Africa and parts of Asia. Emerging research has identified a potential association between poor oral health and ESCC. One possible link between poor oral health and ESCC involves the alteration of the microbiome. We performed an integrated analysis of four independent sequencing efforts of ESCC tumors from patients from high- and low-incidence regions of the world. Using whole genome sequencing (WGS) and RNA sequencing (RNAseq) of ESCC tumors from 61 patients in Tanzania, we identified a community of bacteria, including members of the genera Fusobacterium, Selenomonas, Prevotella, Streptococcus, Porphyromonas, Veillonella and Campylobacter, present at high abundance in ESCC tumors. We then characterized the microbiome of 238 ESCC tumor specimens collected in two additional independent sequencing efforts consisting of patients from other high-ESCC incidence regions (Tanzania, Malawi, Kenya, Iran, China). This analysis revealed similar ESCC-associated bacterial communities in these cancers. Because these genera are traditionally considered members of the oral microbiota, we next explored whether there was a relationship between the synchronous saliva and tumor microbiomes of ESCC patients in Tanzania. Comparative analyses revealed that paired saliva and tumor microbiomes were significantly similar with a specific enrichment of Fusobacterium and Prevotella in the tumor microbiome. Together, these data indicate that cancer-associated oral bacteria are associated with ESCC tumors at the time of diagnosis and support a model in which oral bacteria are present in high abundance in both saliva and tumors of some ESCC patients.
- Published
- 2022
11. Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study
- Author
-
Buckle, Geoffrey C, Mrema, Alita, Mwachiro, Michael, Ringo, Yona, Selekwa, Msiba, Mulima, Gift, Some, Fatma F, Mmbaga, Blandina T, Mody, Gita N, Zhang, Li, Paciorek, Alan, Akoko, Larry, Ayuo, Paul, Burgert, Stephen, Bukusi, Elizabeth, Charles, Anthony, Chepkemoi, Winnie, Chesumbai, Gladys, Kaimila, Bongani, Kenseko, Aida, Kibwana, Kitembo Salum, Koech, David, Macharia, Caren, Moirana, Ezekiel N, Mushi, Beatrice Paul, Mremi, Alex, Mwaiselage, Julius, Mwanga, Ally, Ndumbalo, Jerry, Nvakunga, Gissela, Ngoma, Mamsau, Oduor, Margaret, Oloo, Mark, Opakas, Jesse, Parker, Robert, Seno, Saruni, Salima, Ande, Servent, Furaha, Wandera, Andrew, Westmoreland, Kate D, White, Russell E, Williams, Brittney, Mmbaga, Elia J, and Van Loon, Katherine
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Digestive Diseases ,Health Services ,Rare Diseases ,Comparative Effectiveness Research ,Cancer ,Clinical Research ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Good Health and Well Being ,Adult ,Africa ,Eastern ,Esophageal Neoplasms ,Esophageal Squamous Cell Carcinoma ,Female ,Health Resources ,Humans ,Longitudinal Studies ,Male ,Observational Studies as Topic ,Palliative Care ,Prospective Studies ,Treatment Outcome ,Esophageal squamous cell carcinoma ,Esophageal cancer ,Survival ,Quality of life ,Comparative ,effectiveness ,Africa ,Eastern Africa ,of the African Esophageal Cancer Consortium ,Comparative effectiveness ,Public Health and Health Services ,Oncology & Carcinogenesis ,Oncology and carcinogenesis ,Epidemiology - Abstract
BackgroundEsophageal squamous cell carcinoma (ESCC) is a major cause of cancer morbidity and mortality in Eastern Africa. The majority of patients with ESCC in Eastern Africa present with advanced disease at the time of diagnosis. Several palliative interventions for ESCC are currently in use within the region, including chemotherapy, radiation therapy with and without chemotherapy, and esophageal stenting with self-expandable metallic stents; however, the comparative effectiveness of these interventions in a low resource setting has yet to be examined.MethodsThis prospective, observational, multi-center, open cohort study aims to describe the therapeutic landscape of ESCC in Eastern Africa and investigate the outcomes of different treatment strategies within the region. The 4.5-year study will recruit at a total of six sites in Kenya, Malawi and Tanzania (Ocean Road Cancer Institute and Muhimbili National Hospital in Dar es Salaam, Tanzania; Kilimanjaro Christian Medical Center in Moshi, Tanzania; Tenwek Hospital in Bomet, Kenya; Moi Teaching and Referral Hospital in Eldoret, Kenya; and Kamuzu Central Hospital in Lilongwe, Malawi). Treatment outcomes that will be evaluated include overall survival, quality of life (QOL) and safety. All patients (≥18 years old) who present to participating sites with a histopathologically-confirmed or presumptive clinical diagnosis of ESCC based on endoscopy or barium swallow will be recruited to participate. Key clinical and treatment-related data including standardized QOL metrics will be collected at study enrollment, 1 month following treatment, 3 months following treatment, and thereafter at 3-month intervals until death. Vital status and QOL data will be collected through mobile phone outreach.DiscussionThis study will be the first study to prospectively compare ESCC treatment strategies in Eastern Africa, and the first to investigate QOL benefits associated with different treatments in sub-Saharan Africa. Findings from this study will help define optimal management strategies for ESCC in Eastern Africa and other resource-limited settings and will serve as a benchmark for future research.Trial registrationThis study was retrospectively registered with the ClinicalTrials.gov database on December 15, 2021, NCT05177393 .
- Published
- 2022
12. Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
- Author
-
Katy Cornish, Jiandong Huo, Luke Jones, Parul Sharma, Joseph W. Thrush, Sahar Abdelkarim, Anja Kipar, Siva Ramadurai, Miriam Weckener, Halina Mikolajek, Sai Liu, Imogen Buckle, Eleanor Bentley, Adam Kirby, Ximeng Han, Stephen M. Laidlaw, Michelle Hill, Lauren Eyssen, Chelsea Norman, Audrey Le Bas, John Clarke, William James, James P. Stewart, Miles Carroll, James H. Naismith, and Raymond J. Owens
- Subjects
nanobodies ,Omicrons ,spike protein ,SARS-CoV-2 ,COVID-19 ,Biology (General) ,QH301-705.5 - Abstract
The Omicron strains of SARS-CoV-2 pose a significant challenge to the development of effective antibody-based treatments as immune evasion has compromised most available immune therapeutics. Therefore, in the ‘arms race’ with the virus, there is a continuing need to identify new biologics for the prevention or treatment of SARS-CoV-2 infections. Here, we report the isolation of nanobodies that bind to the Omicron BA.1 spike protein by screening nanobody phage display libraries previously generated from llamas immunized with either the Wuhan or Beta spike proteins. The structure and binding properties of three of these nanobodies (A8, H6 and B5-5) have been characterized in detail providing insight into their binding epitopes on the Omicron spike protein. Trimeric versions of H6 and B5-5 neutralized the SARS-CoV-2 variant of concern BA.5 both in vitro and in the hamster model of COVID-19 following nasal administration. Thus, either alone or in combination could serve as starting points for the development of new anti-viral immunotherapeutics.
- Published
- 2024
- Full Text
- View/download PDF
13. The economic impact of living with a rare disease for children and their families: a scoping review protocol [version 2; peer review: 2 approved, 1 not approved]
- Author
-
Naonori Kodate, Suja Somanadhan, Niamh Buckle, and Orla Doyle
- Subjects
Child ,cost-of-illness ,economic evaluation ,family ,financial hardship ,orphan diseases ,eng ,Medicine - Abstract
Background Rare diseases are an often chronic, progressive and life-limiting group of conditions affecting more than 30 million people in Europe. These diseases are associated with significant direct and indirect costs to a spectrum of stakeholders, ranging from individuals and their families to society overall. Further quantitative research on the economic cost for children and their families living with a rare disease is required as there is little known on this topic. This scoping review aims to document the extent and type of evidence on the economic impacts of living with a rare disease for children and their families. Methods This scoping review will follow the PRISMA-ScR and Joanna Briggs Institute guidelines and follow the six-stage methodology for scoping reviews: (1) identifying the research question, (2) identifying relevant studies, (3) study selection, (4) charting the data, (5) collating, summarising and reporting results and (6) knowledge user consultation. Key inclusion criteria have been developed according to the Population-Concept-Context (PCC) framework. The databases EconLit, ABI/Inform, MEDLINE, PubMed, CINAHL, and Scopus will be searched for possible articles for inclusion. Two independent reviewers will screen titles and abstracts of potential articles using a dual review process to ensure all relevant studies are included. All included articles will be assessed using a validated quality appraisal tool. A panel of patient and public involvement representatives experiencing rare diseases and knowledge users will validate the review results. Conclusions This scoping review will map the current literature on the economic impact of paediatric rare diseases to understand how these impacts affect children living with rare diseases and their families. This evidence has the potential to influence policy and future research in this area and will support further research on the economic impact of rare diseases on families.
- Published
- 2024
- Full Text
- View/download PDF
14. Transcription modulates chromatin dynamics and locus configuration sampling
- Author
-
Forte, Giada, Buckle, Adam, Boyle, Shelagh, Marenduzzo, Davide, Gilbert, Nick, and Brackley, Chris A.
- Published
- 2023
- Full Text
- View/download PDF
15. Climate, caribou and human needs linked by analysis of Indigenous and scientific knowledge
- Author
-
Gagnon, Catherine A., Hamel, Sandra, Russell, Don E., Andre, James, Buckle, Annie, Haogak, David, Pascal, Jessi, Schafer, Esau, Powell, Todd, Svoboda, Michael Y., and Berteaux, Dominique
- Published
- 2023
- Full Text
- View/download PDF
16. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients
- Author
-
Wit, Esther M. K., KleinJan, Gijs H., Berrens, Anne-Claire, van Vliet, Roos, van Leeuwen, Pim J., Buckle, Tessa, Donswijk, Maarten L., Bekers, Elise M., van Leeuwen, Fijs W. B., and van der Poel, Henk G.
- Published
- 2023
- Full Text
- View/download PDF
17. Understanding how shared decision‐making approaches and patient aids influence patients with advanced cancer when deciding on palliative treatments and care: A realist review
- Author
-
Michelle Edwards, Daniella Holland‐Hart, Mala Mann, Kathy Seddon, Peter Buckle, Mirella Longo, Anthony Byrne, and Annmarie Nelson
- Subjects
advanced cancer ,decision support ,palliative care ,palliative treatment ,Medicine (General) ,R5-920 ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Patients with advanced incurable cancer face difficult decisions about palliative treatment options towards their end of life. However, they are often not provided with the appropriate information and support that is needed to make informed decisions. This review aimed to identify contexts and mechanisms associated with communication tools, patient decision‐aids and shared decision‐making (SDM) approaches that influence patient outcomes. Methods We used a realist review method to search for published studies of patients (adults > 18) with advanced cancer who were expected to make a decision about palliative treatment and/or supportive care in consultation with healthcare practitioners. We appraised and synthesised literature describing the contexts of (when and how) decision aids and SDM approaches are used, and how these contexts interact with mechanisms (resources and reasoning) which impact patient outcomes. Stakeholders including academics, palliative healthcare professionals (HCPs) and people with lived experience of supporting people with advanced incurable cancer contributed to identifying explanatory accounts. These accounts were documented, analysed and consolidated to contribute to the development of a programme theory. Results From the 33 included papers, we consolidated findings into 20 explanatory accounts to develop a programme theory that explains key contexts and mechanisms that influence patient and SDM. Contexts include underlying patients' and HCPs' attitudes and approaches. These need to be understood in relation to key mechanisms, including presenting information in multiple formats and providing adequate time and opportunities to prepare for and revisit decisions. Contexts influenced mechanisms which then influence the levels of patient decisional satisfaction, conflict and regret. Conclusions Our programme theory highlights mechanisms that are important in supporting shared treatment decisions for advanced noncurative cancer. The findings are informative for developing and evaluating interventions to improve understanding and involvement in SDM for patients with advanced incurable cancer. Patient and Public Contribution We included patient and public involvement (PPI) representatives in four stakeholder meetings. PPI helped to define the scope of the review, identify their unique experiences and perspectives, synthesise their perspectives with our review findings, make decisions about which theories we included in our programme theory and develop recommendations for policy and practice and future research.
- Published
- 2023
- Full Text
- View/download PDF
18. Augmenting CT-Guided Bone Biopsies Using 18F-FDG PET/CT Guidance
- Author
-
Max F. Droste, Floris H. P. van Velden, Matthias N. van Oosterom, Valentijn J. Luijk, Mark C. Burgmans, Tessa Buckle, Fijs W. B. van Leeuwen, and Daphne D. D. Rietbergen
- Subjects
image-guided bone biopsy ,18F-FDG PET/CT ,CT-guided biopsy ,bone lesions ,histopathology ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Computer tomography (CT)-guided percutaneous core biopsies are currently the gold standard in diagnostic procedures for patients with bone lesions of unknown kind. CT-guided biopsies can lead to misdiagnosis or repetition of biopsies in case of small or heterogeneous lesions. We hypothesize that molecular image guidance could be used to optimize the biopsy strategy, by supporting the detection of heterogeneous lesions or lesions without radiographic substrate. To evaluate this hypothesis, we investigated if and how the addition of 2-deoxy-2-18F-fluoro-D-glucose-positron emission tomography (18F-FDG-PET)/CT could augment routine CT-guided bone biopsies. To this end, 106 patients who underwent a CT-guided bone biopsy between April 2019 and April 2020, obtained from either a vertebral or peripheral bone, were included. Patients were divided into 2 groups: 36 patients received an 18F-FDG-PET/CT scan prior to their CT-guided bone biopsy (PET group), while 70 patients only had a morphological CT scan (CT group). Histopathology was used to categorize biopsies into five subgroups (inconclusive, benign, malignant or infectious disease, or normal tissue). In the PET group, the number of conclusive biopsies was significantly higher compared to the CT group (N = 33/36 (92%) versus N = 53/70 (76%); p < 0.05). Furthermore, the number of first-try biopsies was lower in the PET group compared to the CT group (1.9 vs. 2.54, p = 0.051). In conclusion, 18F-FDG-PET/CT imaging significantly increased the success rate of first-try CT-guided bone biopsies by showing less inconclusive biopsies and misdiagnosis.
- Published
- 2024
- Full Text
- View/download PDF
19. From Llama to Nanobody: A Streamlined Workflow for the Generation of Functionalised VHHs
- Author
-
Lauren E- Eyssen, Siva Ramadurai, Sahar Abdelkarim, Imogen Buckle, Katy Cornish, Hong Lin, A Jones, Gary Stephens, and Raymond Owens
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Nanobodies are recombinant antigen-specific single domain antibodies (VHHs) derived from the heavy chain–only subset of camelid immunoglobulins. Their small molecular size, facile expression, high affinity, and stability have combined to make them unique targeting reagents with numerous applications in the biomedical sciences. From our work in producing nanobodies to over sixty different proteins, we present a standardised workflow for nanobody discovery from llama immunisation, library building, panning, and small-scale expression for prioritisation of binding clones. In addition, we introduce our suites of mammalian and bacterial vectors, which can be used to functionalise selected nanobodies for various applications such as in imaging and purification.Key features• Standardise the process of building nanobody libraries and finding nanobody binders so that it can be repeated in any lab with reasonable equipment.• Introduce two suites of vectors to functionalise nanobodies for production in either bacterial or mammalian cells.Graphical overview
- Published
- 2024
- Full Text
- View/download PDF
20. Rural suicide in Newfoundland and Labrador: A qualitative exploration of health care providers' perspectives.
- Author
-
Tyler R Pritchard, Jennifer L Buckle, Kristel Thomassin, and Stephen P Lewis
- Subjects
Medicine ,Science - Abstract
IntroductionResidents of rural regions may have higher and unique suicide risks. Newfoundland and Labrador (NL) is a Canadian province replete with rural regions. Despite an abundance of rural suicide research, heterogeneity in rural regions may preclude amalgamating findings to inform prevention efforts. Thus, exploring the unique needs of NL is needed. Importantly, health care providers (HCP) may afford unique perspectives on the suicide-related needs or concerns of rural life. We asked HCPs of residents of rural NL their perceived suicide risk factors, concerns, and needs for rural NL.MethodTwelve HCPs of rural residents of NL completed virtual semi-structured interviews. Interviews were analysed using reflexive thematic analysis [13,14].ResultsHCPs noted individual, psychological, social, and practical factors linked to rural-suicide risk and subsequent needs. Findings highlight the unique challenges of residing and providing health care in rural NL and inform prevention and intervention efforts.
- Published
- 2024
- Full Text
- View/download PDF
21. Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis
- Author
-
Cui Tu, Irina Buckle, Ingrid Leal Rojas, Gustavo Rodrigues Rossi, David P Sester, Andrew S Moore, Kristen Radford, Camille Guillerey, and Fernando Souza‐Fonseca‐Guimaraes
- Subjects
AML ,B‐ALL ,NK cells ,NKG2A ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Abstract Objectives Immunotherapies targeting natural killer (NK) cell receptors have shown promise against leukaemia. Unfortunately, cancer immunosuppressive mechanisms that alter NK cell phenotype prevent such approaches from being successful. The study utilises advanced cytometry to examine how cancer immunosuppressive pathways affect NK cell phenotypic changes in clinical samples. Methods In this study, we conducted a high‐dimensional examination of the cell surface expression of 16 NK cell receptors in paediatric patients with acute myeloid leukaemia and acute lymphoblastic leukaemia, as well as in samples of non‐age matched adult peripheral blood (APB) and umbilical cord blood (UCB). An unsupervised analysis was carried out in order to identify NK cell populations present in paediatric leukaemias. Results We observed that leukaemia NK cells clustered together with UCB NK cells and expressed relatively higher levels of the NKG2A receptor compared to APB NK cells. In addition, CD56dimCD16+CD57− NK cells lacking NKG2A expression were mainly absent in paediatric leukaemia patients. However, CD56br NK cell populations expressing high levels of NKG2A were highly represented in paediatric leukaemia patients. NKG2A expression on leukaemia NK cells was found to be positively correlated with the expression of its ligand, suggesting that the NKG2A‐HLA‐E interaction may play a role in modifying NK cell responses to leukaemia cells. Conclusion We provide an in‐depth analysis of NK cell populations in paediatric leukaemia patients. These results support the development of immunotherapies targeting immunosuppressive receptors, such as NKG2A, to enhance innate immunity against paediatric leukaemia.
- Published
- 2024
- Full Text
- View/download PDF
22. Risk Factors Associated With Early-Onset Esophageal Cancer in Tanzania
- Author
-
Buckle, Geoffrey C, Mmbaga, Elia J, Paciorek, Alan, Akoko, Larry, Deardorff, Katrina, Mgisha, William, Mushi, Beatrice P, Mwaiselage, Julius, Hiatt, Robert A, Zhang, Li, and Van Loon, Katherine
- Published
- 2022
23. Views from Multidisciplinary Oncology Clinicians on Strengthening Cancer Care Delivery Systems in Tanzania
- Author
-
Nyagabona, Sarah Kutika, Luhar, Rohan, Ndumbalo, Jerry, Mvungi, Nanzoke, Ngoma, Mamsau, Meena, Stephen, Siu, Sadiq, Said, Mwamvita, Mwaiselage, Julius, Tarimo, Edith, Buckle, Geoffrey, Selekwa, Msiba, Mushi, Beatrice, Mmbaga, Elia John, Van Loon, Katherine, and DeBoer, Rebecca J
- Subjects
Health Services ,Cancer ,Clinical Research ,Health and social care services research ,8.1 Organisation and delivery of services ,7.1 Individual care needs ,Management of diseases and conditions ,Good Health and Well Being ,Aged ,Child ,Delivery of Health Care ,Focus Groups ,Hospitals ,Humans ,Neoplasms ,Tanzania ,Africa ,Cancer care facilities ,Guideline adherence ,Implementation science ,Low- and middle-income countries ,Quality improvement ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis - Abstract
BackgroundIn response to the increasing burden of cancer in Tanzania, the Ministry of Health, Community Development, Gender, Elderly and Children launched National Cancer Treatment Guidelines (TNCTG) in February 2020. The guidelines aimed to improve and standardize oncology care in the country. At Ocean Road Cancer Institute (ORCI), we developed a theory-informed implementation strategy to promote guideline-concordant care. As part of the situation analysis for implementation strategy development, we conducted focus group discussions to evaluate clinical systems and contextual factors that influence guideline-based practice prior to the launch of the TNCTG.Materials and methodsIn June 2019, three focus group discussions were conducted with a total of 21 oncology clinicians at ORCI, stratified by profession. A discussion guide was used to stimulate dialogue about facilitators and barriers to delivery of guideline-concordant care. Discussions were audio recorded, transcribed, translated, and analyzed using thematic framework analysis.ResultsParticipants identified factors both within the inner context of ORCI clinical systems and outside of ORCI. Themes within the clinical systems included capacity and infrastructure, information technology, communication, efficiency, and quality of services provided. Contextual factors external to ORCI included interinstitutional coordination, oncology capacity in peripheral hospitals, public awareness and beliefs, and financial barriers. Participants provided pragmatic suggestions for strengthening cancer care delivery in Tanzania.ConclusionOur results highlight several barriers and facilitators within and outside of the clinical systems at ORCI that may affect uptake of the TNCTG. Our findings were used to inform a broader guideline implementation strategy, in an effort to improve uptake of the TNCTGs at ORCI.Implications for practiceThis study provides an assessment of cancer care delivery systems in a low resource setting from the unique perspectives of local multidisciplinary oncology clinicians. Situational analysis of contextual factors that are likely to influence guideline implementation outcomes is the first step of developing an implementation strategy for cancer treatment guidelines. Many of the barriers identified in this study represent actionable targets that will inform the next phases of our implementation strategy for guideline-concordant cancer care in Tanzania and comparable settings.
- Published
- 2021
24. Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective
- Author
-
Vreeburg, Manon T. A., Azargoshasb, Samaneh, van Willigen, Danny, Molenaar, Tom, van Oosterom, Matthias N., Buckle, Tessa, Slof, Leon J., Klop, Martin, Karakullukcu, Baris, Donswijk, Maarten, van der Poel, Henk G., van Leeuwen, Fijs W. B., Brouwer, Oscar R., and Rietbergen, Daphne D. D.
- Published
- 2023
- Full Text
- View/download PDF
25. Click-on fluorescence detectors: using robotic surgical instruments to characterize molecular tissue aspects
- Author
-
van Oosterom, Matthias N., van Leeuwen, Sven I., Mazzone, Elio, Dell’Oglio, Paolo, Buckle, Tessa, van Beurden, Florian, Boonekamp, Michael, van de Stadt, Huybert, Bauwens, Kevin, Simon, Hervé, van Leeuwen, Pim J., van der Poel, Henk G., and van Leeuwen, Fijs W. B.
- Published
- 2023
- Full Text
- View/download PDF
26. Model for building quality resilient health facility
- Author
-
Elom Hillary Otchi, Nhyira Gyawu, and Gilbert Buckle
- Subjects
quality ,health system ,quality improvement ,accreditation ,standards ,Public aspects of medicine ,RA1-1270 - Abstract
The AfIHQSA Model is the model for building quality resilient health systems. It is proposed as a compliment to and in many instances as an alternative to the many other existing in ensuring a systematic and a sustained approach to improving outcomes in African health systems. It seeks to bring the necessary transformation to healthcare quality and patient safety and facilitate the attainment of desired outcomes. The model is unique in its iterative nature and how it places premium on sustaining the gains of improvement. The authors are concerned about the lack of sustainability of the many quality improvement efforts on the continent and how they all fade out into obscurity upon the exit of the proponents. Six iterative steps are proposed in the use of the model and these are: leadership commitment and buy-in; situational analysis of quality management capacity; systems strengthening for quality management; quality improvement interventions for care outcomes; standardization/accreditation/certification; and iterative monitoring, evaluation of performance of interventions and learning. Most of the quality interventions and efforts on the continent have failed because the steps in this model have not been sufficiently followed and addressed. The required strengthening of the various components of the health system necessary to sufficiently bear the weight of any quality intervention and guarantee sustainability of the gains is often ignored. As authors, we have therefore formally adopted the use of this model and plan to further continue evaluating and monitoring its utility and its generalizability in different institutions and countries.
- Published
- 2023
- Full Text
- View/download PDF
27. Surgisense - adding sense to vision-guided surgery: Fingertip molecular sensing
- Author
-
H.G. Van Der Poel, T. Buckle, M. van Oosterom, and F. van Leeuwen
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2023
- Full Text
- View/download PDF
28. A radio- and fluorescently labelled tracer for imaging and quantification of bacterial infection on orthopaedic prostheses a proof of principle study
- Author
-
Mick M. Welling, Kim Warbroek, Chrow Khurshid, Matthias N. van Oosterom, Daphne D. D. Rietbergen, Mark G. J. de Boer, Rob G. H. H. Nelissen, Fijs W. B. van Leeuwen, Bart G. Pijls, and Tessa Buckle
- Subjects
Infectious diseases ,Orthopaedic surgery ,Image-guided surgery ,Molecular imaging ,Fluorescence-guided surgery ,Radioguided surgery ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
AimsArthroplasty surgery of the knee and hip is performed in two to three million patients annually. Periprosthetic joint infections occur in 4% of these patients. Debridement, antibiotics, and implant retention (DAIR) surgery aimed at cleaning the infected prosthesis often fails, subsequently requiring invasive revision of the complete prosthetic reconstruction. Infection-specific imaging may help to guide DAIR. In this study, we evaluated a bacteria-specific hybrid tracer (99mTc-UBI29-41-Cy5) and its ability to visualize the bacterial load on femoral implants using clinical-grade image guidance methods.Methods99mTc-UBI29-41-Cy5 specificity for Stapylococcus aureus was assessed in vitro using fluorescence confocal imaging. Topical administration was used to highlight the location of S. aureus cultured on femoral prostheses using fluorescence imaging and freehand single photon emission CT (fhSPECT) scans. Gamma counting and fhSPECT were used to quantify the bacterial load and monitor cleaning with chlorhexidine. Microbiological culturing helped to relate the imaging findings with the number of (remaining) bacteria.ResultsBacteria could be effectively stained in vitro and on prostheses, irrespective of the presence of biofilm. Infected prostheses revealed bacterial presence on the transition zone between the head and neck, and in the screw hole. Qualitative 2D fluorescence images could be complemented with quantitative 3D fhSPECT scans. Despite thorough chlorhexidine treatments, 28% to 44% of the signal remained present in the locations of the infection that were identified using imaging, which included 500 to 2,000 viable bacteria.ConclusionThe hybrid tracer 99mTc-UBI29-41-Cy5 allowed effective bacterial staining. Qualitative real-time fluorescence guidance could be effectively combined with nuclear imaging that enables quantitative monitoring of the effectiveness of cleaning strategies.Cite this article: Bone Joint Res 2023;12(1):72–79.
- Published
- 2023
- Full Text
- View/download PDF
29. Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators
- Author
-
Rynearson, Kevin D, Buckle, Ronald N, Herr, R Jason, Mayhew, Nicholas J, Chen, Xinchao, Paquette, William D, Sakwa, Samuel A, Yang, Jinhai, Barnes, Keith D, Nguyen, Phuong, Mobley, William C, Johnson, Graham, Lin, Juinn H, Tanzi, Rudolph E, and Wagner, Steven L
- Subjects
Medicinal and Biomolecular Chemistry ,Chemical Sciences ,Biotechnology ,Development of treatments and therapeutic interventions ,5.1 Pharmaceuticals ,Amyloid Precursor Protein Secretases ,Amyloid beta-Peptides ,Animals ,Cell Line ,Tumor ,Dose-Response Relationship ,Drug ,Drug Design ,Enzyme Inhibitors ,Female ,Humans ,Male ,Mice ,Mice ,Transgenic ,Molecular Structure ,Pyridines ,Structure-Activity Relationship ,Gamma secretase modulator ,Alzheimer's disease ,Amyloid beta ,A beta 42 reduction ,Structure activity relationship ,Methoxypyridines ,Alzheimer’s disease ,Aβ42 reduction ,Organic Chemistry ,Pharmacology and Pharmaceutical Sciences ,Medicinal & Biomolecular Chemistry ,Biochemistry and cell biology ,Medicinal and biomolecular chemistry ,Organic chemistry - Abstract
The evolution of gamma-secretase modulators (GSMs) through the introduction of novel heterocycles with the goal of aligning activity for reducing the levels of Aβ42 and properties consistent with a drug-like molecule are described. The insertion of a methoxypyridine motif within the tetracyclic scaffold provided compounds with improved activity for arresting Aβ42 production as well as improved properties, including solubility. In vivo pharmacokinetic analysis demonstrated that several compounds within the novel series were capable of crossing the BBB and accessing the therapeutic target. Treatment with methoxypyridine-derived compound 64 reduced Aβ42 levels in the plasma of J20 mice, in addition to reducing Aβ42 levels in the plasma and brain of Tg2576 mice.
- Published
- 2020
30. The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions
- Author
-
Edward D. Chan, Paul T. King, Xiyuan Bai, Allen M. Schoffstall, Robert A. Sandhaus, and Ashley M. Buckle
- Subjects
serine protease ,serpin ,TMPRSS2 ,heparin ,glycosaminoglycans ,C1-esterase inhibitor ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Serine proteases are members of a large family of hydrolytic enzymes in which a particular serine residue in the active site performs an essential role as a nucleophile, which is required for their proteolytic cleavage function. The array of functions performed by serine proteases is vast and includes, among others, the following: (i) the ability to fight infections; (ii) the activation of blood coagulation or blood clot lysis systems; (iii) the activation of digestive enzymes; and (iv) reproduction. Serine protease activity is highly regulated by multiple families of protease inhibitors, known collectively as the SERine Protease INhibitor (SERPIN). The serpins use a conformational change mechanism to inhibit proteases in an irreversible way. The unusual conformational change required for serpin function provides an elegant opportunity for allosteric regulation by the binding of cofactors, of which the most well-studied is heparin. The goal of this review is to discuss some of the clinically relevant serine protease–serpin interactions that may be enhanced by heparin or other negatively charged polysaccharides. The paired serine protease–serpin in the framework of heparin that we review includes the following: thrombin–antithrombin III, plasmin–anti-plasmin, C1 esterase/kallikrein–C1 esterase inhibitor, and furin/TMPRSS2 (serine protease Transmembrane Protease 2)–alpha-1-antitrypsin, with the latter in the context of COVID-19 and prostate cancer.
- Published
- 2024
- Full Text
- View/download PDF
31. WebNORM: a web application for calculating normative mineralogy
- Author
-
Tom Buckle, Morgan Williams, Chetan L. Nathwani, and Hannah S. R. Hughes
- Subjects
normative mineralogy ,CIPW ,mineralogy ,web app ,python ,Science - Abstract
Normative mineralogy is a valuable tool for interpreting the mineralogical composition of rocks based on their bulk rock geochemical data. Despite the development of various computational tools for normative mineralogy calculations, the accessibility and continued usage of many existing tools is limited by the use of older languages, licensing constraints, and restricted access to the source code. In this paper, we introduce a Python-based implementation of the normative mineralogy algorithm, which is accessible through a user-friendly web application webNORM, or as part of the pyrolite Python package. The algorithm uses major, minor, and trace element oxides as input and returns up to 31 normative minerals. It offers two methods for estimating the Fe2O3:FeO ratio. The web application offers a convenient interface for users without programming experience, while the pyrolite integration allows more advanced users to leverage the Python ecosystem for end-to-end geochemical data analysis. Comparison between our implementation of the normative calculation and previous implementations shows that our version is accurate and reliable. webNORM offers the geoscience community an accessible solution for calculating normative mineralogy. The algorithm and web application are open-source, and we encourage contributions and adaptations by the community for specific needs and improvements.
- Published
- 2023
- Full Text
- View/download PDF
32. Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline
- Author
-
Stone, P., Buckle, P., Dolan, R., Feliu, J., Hui, D., Laird, B.J.A., Maltoni, M., Moine, S., Morita, T., Nabal, M., Vickerstaff, V., White, N., Santini, D., and Ripamonti, C.I.
- Published
- 2023
- Full Text
- View/download PDF
33. Development of a theory-driven implementation strategy for cancer management guidelines in sub-Saharan Africa
- Author
-
DeBoer, Rebecca J, Ndumbalo, Jerry, Meena, Stephen, Ngoma, Mamsau T, Mvungi, Nanzoke, Siu, Sadiq, Selekwa, Msiba, Nyagabona, Sarah K, Luhar, Rohan, Buckle, Geoffrey, Lin, Tracy Kuo, Breithaupt, Lindsay, Kennell-Heiling, Stephanie, Mushi, Beatrice, Philipo, Godfrey Sama, Mmbaga, Elia J, Mwaiselage, Julius, and Van Loon, Katherine
- Published
- 2020
34. On-microscope staging of live cells reveals changes in the dynamics of transcriptional bursting during differentiation
- Author
-
D. M. Jeziorska, E. A. J. Tunnacliffe, J. M. Brown, H. Ayyub, J. Sloane-Stanley, J. A. Sharpe, B. C. Lagerholm, C. Babbs, A. J. H. Smith, V. J. Buckle, and D. R. Higgs
- Subjects
Science - Abstract
Here the authors observe transcription dynamics in real-time throughout erythropoiesis by combining PP7 tagging of α-globin RNA transcripts and “on-microscope” cell staging. They show how the pattern of transcriptional bursting changes during differentiation, with variability in individual cells significantly reduced at the peak period of gene expression.
- Published
- 2022
- Full Text
- View/download PDF
35. Diet and irritable bowel syndrome: an update from a UK consensus meeting
- Author
-
A. Rej, A. Avery, I. Aziz, C. J. Black, R. K. Bowyer, R. L. Buckle, L. Seamark, C. C. Shaw, J. Thompson, N. Trott, M. Williams, and D. S. Sanders
- Subjects
Irritable bowel syndrome ,Low FODMAP diet ,Gluten-free diet ,Traditional dietary advice ,Medicine - Abstract
Abstract There has been a renewed interest in the role of dietary therapies to manage irritable bowel syndrome (IBS), with diet high on the agenda for patients. Currently, interest has focussed on the use of traditional dietary advice (TDA), a gluten-free diet (GFD) and the low FODMAP diet (LFD). A consensus meeting was held to assess the role of these dietary therapies in IBS, in Sheffield, United Kingdom. Evidence for TDA is from case control studies and clinical experience. Randomised controlled trials (RCT) have demonstrated the benefit of soluble fibre in IBS. No studies have assessed TDA in comparison to a habitual or sham diet. There have been a number of RCTs demonstrating the efficacy of a GFD at short-term follow-up, with a lack of long-term outcomes. Whilst gluten may lead to symptom generation in IBS, other components of wheat may also play an important role, with recent interest in the role of fructans, wheat germ agglutinins, as well as alpha amylase trypsin inhibitors. There is good evidence for the use of a LFD at short-term follow-up, with emerging evidence demonstrating its efficacy at long-term follow-up. There is overlap between the LFD and GFD with IBS patients self-initiating gluten or wheat reduction as part of their LFD. Currently, there is a lack of evidence to suggest superiority of one diet over another, although TDA is more acceptable to patients. In view of this evidence, our consensus group recommends that dietary therapies for IBS should be offered by dietitians who first assess dietary triggers and then tailor the intervention according to patient choice. Given the lack of dietetic services, novel approaches such as employing group clinics and online webinars may maximise capacity and accessibility for patients. Further research is also required to assess the comparative efficacy of dietary therapies to other management strategies available to manage IBS.
- Published
- 2022
- Full Text
- View/download PDF
36. Human centromere repositioning activates transcription and opens chromatin fibre structure
- Author
-
Catherine Naughton, Covadonga Huidobro, Claudia R. Catacchio, Adam Buckle, Graeme R. Grimes, Ryu-Suke Nozawa, Stefania Purgato, Mariano Rocchi, and Nick Gilbert
- Subjects
Science - Abstract
In this study, using a human neocentromere as a model, the authors show that centromeres have a special chromatin structure. Centromere repositioning triggers transcriptional activation, epigenetic remodelling and chromatin fibre decompaction.
- Published
- 2022
- Full Text
- View/download PDF
37. Communication of palliative care needs in discharge letters from hospice providers to primary care: a multisite sequential explanatory mixed methods study
- Author
-
Katharine Weetman, Jeremy Dale, Sarah J. Mitchell, Claire Ferguson, Anne M. Finucane, Peter Buckle, Elizabeth Arnold, Gemma Clarke, Despoina-Elvira Karakitsiou, Tracey McConnell, Nikhil Sanyal, Anna Schuberth, Georgia Tindle, Rachel Perry, Bhajneek Grewal, Katarzyna A. Patynowska, and John I. MacArtney
- Subjects
Palliative care ,Hospice care ,Patient discharge summaries ,Transitional care ,Communication ,Special situations and conditions ,RC952-1245 - Abstract
Abstract Background The provision of palliative care is increasing, with many people dying in community-based settings. It is essential that communication is effective if and when patients transition from hospice to community palliative care. Past research has indicated that communication issues are prevalent during hospital discharges, but little is known about hospice discharges. Methods An explanatory sequential mixed methods study consisting of a retrospective review of hospice discharge letters, followed by hospice focus groups, to explore patterns in communication of palliative care needs of discharged patients and describe why these patients were being discharged. Discharge letters were extracted for key content information using a standardised form. Letters were then examined for language patterns using a linguistic methodology termed corpus linguistics. Thematic analysis was used to analyse the focus group transcripts. Findings were triangulated to develop an explanatory understanding of discharge communication from hospice care. Results We sampled 250 discharge letters from five UK hospices whereby patients had been discharged to primary care. Twenty-five staff took part in focus groups. The main reasons for discharge extracted from the letters were symptoms “managed/resolved” (75.2%), and/or the “patient wishes to die/for care at home” (37.2%). Most patients had some form of physical needs documented on the letters (98.4%) but spiritual needs were rarely documented (2.4%). Psychological/emotional needs and social needs were documented in 46.4 and 35.6% of letters respectively. There was sometimes ambiguity in “who” will be following up “what” in the discharge letters, and whether described patients’ needs were resolved or ongoing for managing in the community setting. The extent to which patients received a copy of their discharge letter varied. Focus groups conveyed a lack of consensus on what constitutes “complexity” and “complex pain”. Conclusions The content and structure of discharge letters varied between hospices, although generally focused on physical needs. Our study provides insights into patterns associated with those discharged from hospice, and how policy and guidance in this area may be improved, such as greater consistency of sharing letters with patients. A patient-centred set of hospice-specific discharge letter principles could help improve future practice.
- Published
- 2022
- Full Text
- View/download PDF
38. The current status and future prospects for molecular imaging-guided precision surgery
- Author
-
Imke Boekestijn, Matthias N. van Oosterom, Paolo Dell’Oglio, Floris H. P. van Velden, Martin Pool, Tobias Maurer, Daphne D. D. Rietbergen, Tessa Buckle, and Fijs W. B. van Leeuwen
- Subjects
Image-guided therapy ,Intraoperative molecular imaging ,Surgery ,Fluorescence imaging ,Multimodal imaging ,Digital surgery ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Molecular imaging technologies are increasingly used to diagnose, monitor, and guide treatment of i.e., cancer. In this review, the current status and future prospects of the use of molecular imaging as an instrument to help realize precision surgery is addressed with focus on the main components that form the conceptual basis of intraoperative molecular imaging. Paramount for successful interventions is the relevance and accessibility of surgical targets. In addition, selection of the correct combination of imaging agents and modalities is critical to visualize both microscopic and bulk disease sites with high affinity and specificity. In this context developments within engineering/imaging physics continue to drive the growth of image-guided surgery. Particularly important herein is enhancement of sensitivity through improved contrast and spatial resolution, features that are critical if sites of cancer involvement are not to be overlooked during surgery. By facilitating the connection between surgical planning and surgical execution, digital surgery technologies such as computer-aided visualization nicely complement these technologies. The complexity of image guidance, combined with the plurality of technologies that are becoming available, also drives the need for evaluation mechanisms that can objectively score the impact that technologies exert on the performance of healthcare professionals and outcome improvement for patients.
- Published
- 2022
- Full Text
- View/download PDF
39. Pathway map development for medical device event reporting in operating theatres: a human factors approach to improving the existing system
- Author
-
George Hanna, Peter Buckle, Melody Ni, Massimo Micocci, and Arkeliana Tase
- Subjects
Medical technology ,R855-855.5 ,Surgery ,RD1-811 - Abstract
Objectives This study aimed to develop the actual pathway to reporting and information transfer in operating theatres in relation to medical technology malfunction/failure. This with the aim of understanding the differences with the pathway published by NHS Improvement and identification of points for improvement.Design This is a qualitative study involving stakeholder interviews with doctors, nurses, manufacturers, medical device safety officer and Medicines and Healthcare products Regulatory Agency.Setting Data were collected on reporting pathway used in operating theatres. Clinical staff who took part worked in different trusts throughout UK while manufacturers provided devices in UK and EU/USA.Participants Semistructured interviews were completed with 15 clinicians and 13 manufacturers. Surveys were completed by 38 clinicians and 5 manufacturers. Recognised methods of pathway development were used. The Lean Six Sigma principles adapted to healthcare were used to develop suggestions for improvement.Main outcome measures To identify the differences between the set pathway to reporting and information transfer to what is occurring on a day-to-day basis as reported by staff. Identify points in the pathway where improvements could be applied.Results The developed pathway demonstrated great complexity of the current reporting system for medical devices. It identified numerous areas that give rise to problems and multiple biases in decision making. This highlighted the core issues leading to under-reporting and lack of knowledge on device performance and patient risk. Suggestions for improvement were deduced based on end user requirements and identified problems.Conclusions This study has provided a detailed understanding of the key problem areas that exist within the current reporting system for medical devices and technology. The developed pathway sets to address the key problems to improve reporting outcomes. The identification of pathway differences between ‘work as done’ and ‘work as imagined’ can lead to development of quality improvements that could be systematically applied.
- Published
- 2023
- Full Text
- View/download PDF
40. Sources of convergence and divergence in university research quality: evidence from the performance-based research funding system in New Zealand
- Author
-
Buckle, Robert A., Creedy, John, and Gemmell, Norman
- Published
- 2022
- Full Text
- View/download PDF
41. RASER-FISH: non-denaturing fluorescence in situ hybridization for preservation of three-dimensional interphase chromatin structure
- Author
-
Brown, Jill M., De Ornellas, Sara, Parisi, Eva, Schermelleh, Lothar, and Buckle, Veronica J.
- Published
- 2022
- Full Text
- View/download PDF
42. The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection
- Author
-
Wit, Esther M. K., van Beurden, Florian, Kleinjan, Gijs H., Grivas, Nikolaos, de Korne, Clarize M., Buckle, Tessa, Donswijk, Maarten L., Bekers, Elise M., van Leeuwen, Fijs W. B., and van der Poel, Henk G.
- Published
- 2022
- Full Text
- View/download PDF
43. The JCMT Gould Belt Survey: SCUBA-2 Data-Reduction Methods and Gaussian Source Recovery Analysis
- Author
-
Kirk, Helen, Hatchell, Jennifer, Johnstone, Doug, Berry, David, Jenness, Tim, Buckle, Jane, Mairs, Steve, Rosolowsky, Erik, Di Francesco, James, Sadavoy, Sarah, Currie, Malcolm, Broekhoven-Fiene, Hannah, Mottram, Joseph C., Pattle, Kate, Matthews, Brenda, Knee, Lewis B. G., Moriarty-Schieven, Gerald, Duarte-Cabral, Ana, Tisi, Sam, and Ward-Thompson, Derek
- Subjects
Astrophysics - Astrophysics of Galaxies ,Astrophysics - Instrumentation and Methods for Astrophysics - Abstract
The JCMT Gould Belt Survey was one of the first Legacy Surveys with the James Clerk Maxwell Telescope in Hawaii, mapping 47 square degrees of nearby (< 500 pc) molecular clouds in both dust continuum emission at 850 $\mu$m and 450 $\mu$m, as well as a more-limited area in lines of various CO isotopologues. While molecular clouds and the material that forms stars have structures on many size scales, their larger-scale structures are difficult to observe reliably in the submillimetre regime using ground-based facilities. In this paper, we quantify the extent to which three subsequent data-reduction methods employed by the JCMT GBS accurately recover emission structures of various size scales, in particular, dense cores which are the focus of many GBS science goals. With our current best data-reduction procedure, we expect to recover 100% of structures with Gaussian sigma sizes of $\le$30" and intensity peaks of at least five times the local noise for isolated peaks of emission. The measured sizes and peak fluxes of these compact structures are reliable (within 15% of the input values), but source recovery and reliability both decrease significantly for larger emission structures and for fainter peaks. Additional factors such as source crowding have not been tested in our analysis. The most recent JCMT GBS data release includes pointing corrections, and we demonstrate that these tend to decrease the sizes and increase the peak intensities of compact sources in our dataset, mostly at a low level (several percent), but occasionally with notable improvement., Comment: Accepted for publication in ApJS
- Published
- 2018
- Full Text
- View/download PDF
44. Which is better, a SCoTSS gamma imager, or an ARDUO UAV-borne directional detector?
- Author
-
McCann, Andrew, Sinclair, Laurel E., Saull, Patrick R. B., Van Ouellet, Christian, Fortin, Richard, Chen, Carolyn, Coyle, Maurice J., Mantifel, Rodger, MacLeod, Audrey M. L., Van Brabant, Reid A., Buckle, John, Drouin, Pierre-Luc, Hovgaard, Jens, Krupskyy, Bohdan, Beckman, Blake, and Fairbrother, Blaine
- Subjects
Physics - Instrumentation and Detectors - Abstract
The SiPM-based Compton Telescope for Safety and Security (SCoTSS) has been developed with inorganic crystalline scintillator material for gamma detection. The instrument is sensitive enough to be used in a mobile survey mode, accumulating energy deposited in any crystal second-by-second and tagging these spectra with GPS position. The SCoTSS imager of course has the additional advantage of being able to produce an image of the radioactive objects in its field of view using events that satisfy a coincidence trigger between the scatter and absorber layers. The Advanced Radiation Detector for UAV Operations (ARDUO) on the other hand, is a non-imaging directional detector intended for use aboard a small unmanned aerial vehicle (UAV). The ARDUO detector features exactly the same volume of CsI(Tl) as is used in the absorber layer of a single SCoTSS module, giving it similar detection and alarming sensitivity, and map-making capability. However, in the ARDUO detector, the crystals are arranged closely together to optimize direction determination from self-shielding effects. Flown in a grid pattern with a UAV over an area of extended contamination, the ARDUO detector is also capable of making a map or image of that area. With its close-packed crystal arrangement, the ARDUO detector makes a poor Compton imager but does have some ability to produce a peripheral image in a fly-by. In this presentation we investigate the relative merits of Compton imaging versus mobile directional detection., Comment: 6 pages, 4 figures, To appear in the proceedings of the 2017 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC)
- Published
- 2018
45. The JCMT Gould Belt Survey: A First Look at the Auriga-California Molecular Cloud with SCUBA-2
- Author
-
Broekhoven-Fiene, H., Matthews, B. C., Harvey, P., Kirk, H., Chen, M., Currie, M. J., Pattle, K., Lane, J., Buckle, J., Di Francesco, J., Drabek-Maunder, E., Johnstone, D., Berry, D. S., Fich, M., Hatchell, J., Jenness, T., Mottram, J. C., Nutter, D., Pineda, J. E., Quinn, C., Salji, C., Tisi, S., Hogerheijde, M. R., Ward-Thompson, D., Bastien, P., Bresnahan, D., Butner, H., Chrysostomou, A., Coude, S., Davis, C. J., Duarte-Cabral, A., Fiege, J., Friberg, P., Friesen, R., Fuller, G. A., Graves, S., Greaves, J., Gregson, J., Holland, W., Joncas, G., Kirk, J. M., Knee, L. B. G., Mairs, S., Marsh, K., Moriarty-Schieven, G., Mowat, C., Rawlings, J., Richer, J., Robertson, D., Rosolowsky, E., Rumble, D., Sadavoy, S., Thomas, H., Tothill, N., Viti, S., White, G. J., Wilson, C. D., Wouterloot, J., Yates, J., and Zhu, M.
- Subjects
Astrophysics - Astrophysics of Galaxies - Abstract
We present 850 and 450 micron observations of the dense regions within the Auriga-California molecular cloud using SCUBA-2 as part of the JCMT Gould Belt Legacy Survey to identify candidate protostellar objects, measure the masses of their circumstellar material (disk and envelope), and compare the star formation to that in the Orion A molecular cloud. We identify 59 candidate protostars based on the presence of compact submillimeter emission, complementing these observations with existing Herschel/SPIRE maps. Of our candidate protostars, 24 are associated with young stellar objects (YSOs) in the Spitzer and Herschel/PACS catalogs of 166 and 60 YSOs, respectively (177 unique), confirming their protostellar nature. The remaining 35 candidate protostars are in regions, particularly around LkHalpha 101, where the background cloud emission is too bright to verify or rule out the presence of the compact 70 micron emission that is expected for a protostellar source. We keep these candidate protostars in our sample but note that they may indeed be prestellar in nature. Our observations are sensitive to the high end of the mass distribution in Auriga-Cal. We find that the disparity between the richness of infrared star forming objects in Orion A and the sparsity in Auriga-Cal extends to the submillimeter, suggesting that the relative star formation rates have not varied over the Class II lifetime and that Auriga-Cal will maintain a lower star formation efficiency., Comment: 39 pages (54 including the Appendix), 9 figures, 3 tables, in press in ApJ
- Published
- 2018
- Full Text
- View/download PDF
46. Direct measurement of building transient and residual drift using an optical sensor system
- Author
-
Petrone, Floriana, McCallen, David, Buckle, Ian, and Wu, Suiwen
- Subjects
Civil Engineering ,Engineering ,Materials Engineering ,Interdisciplinary Engineering ,Civil engineering ,Materials engineering - Abstract
Interstory drift (ID) is a key response parameter for buildings subjected to lateral loads and is used to define performance-based limit states, allowable deformations and damage states in a number of seismic design codes and standards. An ability to rapidly and accurately measure both transient and residual ID during an earthquake would provide important observables for understanding the seismic demands and post-earthquake condition of a building. Accurate retrieval of ID from accelerometer-based instrumentation systems can be very challenging, if not impossible, as a result of instrumentation limitations and the post-processing associated with strong motion accelerometer data. This is particularly true for the case in which residual drifts occur during inelastic building response. In the study presented herein, a newly developed optical sensor system, designed specifically for directly measuring both transient and residual ID, was experimentally evaluated through shake table testing and computational simulations. The ability of the sensor to accurately measure ID is demonstrated and key operational considerations for sensor system deployment are examined through a model-based investigation.
- Published
- 2018
47. Direct measurement of building transient and residual drift using an optical sensor system
- Author
-
Petrone, F, McCallen, D, Buckle, I, and Wu, S
- Subjects
Civil Engineering ,Materials Engineering ,Interdisciplinary Engineering - Abstract
Interstory drift (ID) is a key response parameter for buildings subjected to lateral loads and is used to define performance-based limit states, allowable deformations and damage states in a number of seismic design codes and standards. An ability to rapidly and accurately measure both transient and residual ID during an earthquake would provide important observables for understanding the seismic demands and post-earthquake condition of a building. Accurate retrieval of ID from accelerometer-based instrumentation systems can be very challenging, if not impossible, as a result of instrumentation limitations and the post-processing associated with strong motion accelerometer data. This is particularly true for the case in which residual drifts occur during inelastic building response. In the study presented herein, a newly developed optical sensor system, designed specifically for directly measuring both transient and residual ID, was experimentally evaluated through shake table testing and computational simulations. The ability of the sensor to accurately measure ID is demonstrated and key operational considerations for sensor system deployment are examined through a model-based investigation.
- Published
- 2018
48. The blind men and the elephant: The case for a transdiagnostic approach to initiation
- Author
-
Karen Leneh Buckle, Ellen Poliakoff, and Emma Gowen
- Subjects
initiation ,autism ,schizophrenia ,Parkinson’s ,catatonia ,transdiagnostic ,Psychology ,BF1-990 - Abstract
Difficulty initiating voluntary action is an under-recognized and often invisible impairment in various psychiatric, neurodevelopmental, and neurological conditions. Understanding the commonalities of volition impairments across diagnoses is limited by a lack of consistent terminology, arbitrary distinctions between conditions, the habit of looking only to the prevailing definitions and theories to explain observed traits, and the covert nature of initiation. The siloed approach to research in this area evokes the parable of the blind men and the elephant, where understanding the whole picture is impeded by a limited view. There has been little effort to consider how differing terms overlap or to use objective methods to differentiate phenomena along meaningful lines. We propose a triad of interacting elements, all of which are needed for successful initiation of voluntary action: (i) executive function, (ii) volition, and (iii) movement. Failure to initiate a response may be due to impairments in any of these, which often co-occur. This paper calls for the following considerations to improve research in this area: (i) put aside preconceptions about conditions and their mechanisms to adopt a flexible transdiagnostic approach; (ii) consider executive function, movement, and volition as possible dimensional variations with related underlying mechanisms; (iii) carefully differentiate components of complex functions; (iv) look to first-hand reports for covert and previously unrecognized traits. These approaches have the potential to elucidate the cognitive and biological mechanisms underpinning voluntary action and create a foundation to develop more appropriate and informed interventions.
- Published
- 2023
- Full Text
- View/download PDF
49. Human Papillomavirus–Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review
- Author
-
Samuel Okerosi, Lillian Wairimu Mokoh, Fidel Rubagumya, Brandon Asuman Niyibizi, Aslam Nkya, Katherine Van Loon, Geoffrey Buckle, Stephen Bent, Patrick Ha, Johannes J. Fagan, Dianna Ng, Joyce Aswani, and Mary Jue Xu
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
PURPOSEThe proportion of head and neck cancers (HNCs) with human papillomavirus (HPV) positivity in sub-Saharan Africa (SSA) is poorly characterized. Characterizing this has implications in staging, prognosis, resource allocation, and vaccination policies. This study aims to determine the proportion of HPV-associated HNC in SSA.MATERIALS AND METHODSThis systematic review included searches from PubMed, EMBASE, Web of Science, African Index Medicus, Google Scholar, and African Journals Online. All English publications reporting the proportion of HNC specimens from SSA patients who tested positive for HPV and/or p16 were included. Study quality was assessed using the National Institutes of Health Quality Assessment Tool for Case Series Studies.RESULTSIn this systematic review of 31 studies and 3,850 patients, the overall p16 positivity was 13.6% (41 of 1,037 patients tested) with the highest proportion among oropharyngeal cancers (20.3%, 78 of 384 patients) and the overall HPV polymerase chain reaction positivity was 15.3% (542 of 3,548 samples tested) with the highest proportion among nasopharyngeal cancers (16.5%, 23 of 139 patients). Among the 369 HPV strains detected, the most common genotypes were HPV 16 (226 patients, 59.2%) and HPV 18 (78, 20.4%).CONCLUSIONHPV was found to be associated with a significant proportion of HNC in SSA. The genotypes reported suggest that the nine-valent vaccine and gender-neutral vaccination policies should be considered. Given that these studies may not accurately capture prevalence nor causation of HPV in HNC subsites, additional research is needed to provide a more thorough epidemiologic understanding of HPV-associated HNC in SSA, including risk factors and clinical outcomes.
- Published
- 2023
- Full Text
- View/download PDF
50. Parent Perceptions of Participation in a Parent-Mediated Communication-Focussed Intervention with Their Young Child with Autism Spectrum Disorder
- Author
-
Leadbitter, Kathy, Macdonald, Wendy, Taylor, Carol, and Buckle, Karen Leneh
- Abstract
Paediatric Autism Communication Therapy is a parent-mediated, video-aided, communication-focussed intervention for young children with autism spectrum disorder. It has been shown in a UK randomised controlled trial to lead to improvements in parent--child communication and family quality of life, together with a sustained reduction in child autism symptom severity. This qualitative study examined parental perceptions of their participation in Paediatric Autism Communication Therapy within the context of the randomised controlled trial. Semi-structured interviews were carried out with 18 parents within 12 months of completion of the therapy. The thematic analysis provides insights into parents' hopes, expectations, and learning processes when working with Paediatric Autism Communication Therapy therapists and carrying out daily practice in the home. Parents reported positive changes in their interaction and relationship with their child and improvements to their child's communication and interaction. Some also highlighted poignant realisations and emotional challenges associated with taking part in this post-diagnostic therapy. Practical difficulties were also emphasised. Implications for the clinical practice of parent-mediated interventions with young children with autism spectrum disorder are discussed. [This article was written with the PACT Consortium.]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.